Q1 2025 Danaher Corp Earnings Call Transcript
Key Points
- Danaher Corp (DHR) reported first-quarter revenue, earnings, and cash flow ahead of expectations, driven by strong momentum in bioprocessing and higher-than-anticipated respiratory demand at Cepheid.
- The company achieved a gross profit margin of 61.2%, up 100 basis points year-over-year, indicating improved profitability.
- Danaher Corp (DHR) generated $1.1 billion of free cash flow in the quarter, resulting in a free cash flow to net income conversion ratio of more than 110%.
- The company is making significant investments in long-term growth initiatives, resulting in impactful new product launches across its Biotechnology, Life Sciences, and Diagnostics segments.
- Bioprocessing segment showed strong performance with core revenue increasing by 7%, driven by low double-digit growth in consumables and robust demand for commercialized therapies.
- Core revenue in the Life Sciences segment decreased by 4%, with a decline in life sciences instrument businesses and weaker demand for plasmids and mRNA.
- Core revenue in the Diagnostics segment declined by 1.5%, impacted by volume-based procurement and reimbursement changes in China.
- The company faces several hundred million dollars in gross impact from tariffs, although it plans to offset this through supply chain adjustments and other measures.
- Danaher Corp (DHR) experienced a high single-digit decline in core revenues within China, primarily affecting its diagnostics businesses.
- The macroeconomic environment remains dynamic with rising geopolitical and trade tensions, contributing to greater uncertainty across global markets.
My name is Chelsea, and I will be your conference facilitator this morning. At this time, I would like to welcome everyone to Danaher Corporation's first-quarter 2025 earnings results conference call. (Operator Instructions)
I will now turn the call over to Mr. John Bedford, Vice President of Investor Relations. Mr. Bedford, you may begin your conference.
Good morning, everyone, and thanks for joining us on the call. With us today are Rainer Blair, our President and Chief Executive Officer; and Matt McGrew, our Executive Vice President and Chief Financial Officer.
I'd like to point out that our earnings release, quarterly report on Form 10-Q, the slide presentation supplementing today's call, the reconciliations, and other information required by SEC Regulation G relating to any non-GAAP financial measures provided during the call and a note containing details of historical and anticipated future financial performance are all available on the Investors section of our website,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
